Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions. 

 

View bio business grants awarded by year.
Zeeshan H. Syedain, PhD
Bioreactor for GMP manufacturing of Tissue Engineered Vascular Graft for Pediatric Regeneration
The project aims at developing a bioreactor system for tissue engineered vascular grafts for pediatric regenerative applications. The specialized…
2016-2017
Amir A. Naqwi, PhD
Airway cell and nutrient delivery device for regenerative lung tissue
The purpose of this project is to develop means for delivering cells and nutrients to the airways of regenerative lung tissue. A novel aerosolizing…
2016-2017
image of Dr. Atta Behfar, MD, PhD
Dr. Atta Behfar, MD, PhD
Advanced Product Incubator Capital Equipment
Regenerative medicine is a branch of medicine that focuses on the rejuvenation, replacement, and regeneration of human cells, tissues, and organs…
2015-2016
Lukkana Suksanpaisan, PhD
Reporter Gene Services in Support of Regenerative Medicines
As the regenerative medicine field continues to grow, more researchers and scientists are depending upon contracted services to provide vital…
2015-2016
Allan B. Dietz, PhD
Mill Creek Life Sciences Cell Kinetics
Mill Creek Life Sciences produces materials that provide the nutrients and growth factors needed to develop cells used in regenerative medicine.…
2015-2016
image of John Brekke, DDS
John Brekke, DDS
Equipment to Support Regenerative Medicine Researchers
Laboratories have traditionally used petri dishes to grow flat, 2-dimensional cells. Substances in the petri dishes, such as agar, provide the…
2015-2016
Dr. Brenda Ogle, PhD
Investigating Cellular Therapeutics for Aneurysm
About six million people in the United States have an unruptured brain aneurysm, according to the Brain Aneurysm Foundation, which means that one…
2015-2016
image of Dr. Daniel Carlson
Daniel F. Carlson, PhD
A new lab for improved testing
Before a new regenerative therapy can be tested on humans, researchers must show that the therapy is safe and effective in animals. Animal testing…
2015-2016
Matt Nelson
Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells
Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells; An Efficient, Highly Sensitive Means of Establishing a Quality…
2015-2016
image of James R Dutton
James R. Dutton, PhD
Manufacturing Cell Therapies using Induced Pluripotent Stem Cells in Minnesota
For years, embryonic stem (ES) cells have shown great promise in helping to stimulate our body’s own ability to heal, but there are limitations to…
2015-2016